Shuping Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuping Jiang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
De Zhang
Department of Pathology, Ganzhou Cancer Hospital, Gannan Medical University, Ganzhou 341000, China; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China
2 shared publicationsYiran Qin
Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, 341000, China; Jiangxi Provincial Key Laboratory of Tissue Engineering, Gannan Medical University, Ganzhou, 341000, China
2 shared publicationsChenxin Shangguan
First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China
1 shared publicationChunming Xu
Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou 341000, China; Jiangxi Provincial Key Laboratory of Tissue Engineering, Ganzhou, 341000, China; School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China
1 shared publicationDong-Kun Zheng
National Engineering Research Center for Modernization of Traditional Chinese Medicine − Hakka Medical Resources Branch, College of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, China
1 shared publicationJia-Wei Hu
Key Laboratory of Biomaterials and Bio-fabrication in Tissue Engineering of Jiangxi Province, Scientific Research Center, Gannan Medical University, Ganzhou, Jiangxi, China
1 shared publication
Latest Publications
- 29 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153220
Comprehensive pharmacological insights into Glaucocalyxin A: Mechanisms and therapeutic potential
- 29 December 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 797, 153220
Comprehensive pharmacological insights into Glaucocalyxin A: Mechanisms and therapeutic potential
- 10 November 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156218
Altingia chinensis petroleum ether extract suppresses NSCLC via induction of apoptosis, attenuation of EMT, and downregulation of PI3K/Akt pathway
- 10 November 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156218
Altingia chinensis petroleum ether extract suppresses NSCLC via induction of apoptosis, attenuation of EMT, and downregulation of PI3K/Akt pathway
- 4 April 2022
- Published by Taylor & Francis in Natural Product Research
- Vol. 36 (23) , 6006-6011
Abietane diterpenoids with neuroprotective activities from Phlegmariurus carinatus
Two new abietane diterpenoids, phlecarinatone A (1) and phlecarinatone B (2), along with two known analogues (3 and 4), were isolated from Phlegmariurus carinatus. The structures of 1 − 4 were unambiguously elucidated by comprehensive spectroscopic analyses. Abietane diterpenoids were isolated from the plant for the first time. All isolates were tested for their neuroprotective activities against H2O2-induced SH-SY5Y cells injury, and compound 2 showed moderate effect at the concentrations ranging from 5 ∼ 20 μM in vitro assay. Graphical Abstract
- 4 April 2022
- Published by Taylor & Francis in Natural Product Research
- Vol. 36 (23) , 6006-6011
Abietane diterpenoids with neuroprotective activities from Phlegmariurus carinatus
Two new abietane diterpenoids, phlecarinatone A (1) and phlecarinatone B (2), along with two known analogues (3 and 4), were isolated from Phlegmariurus carinatus. The structures of 1 − 4 were unambiguously elucidated by comprehensive spectroscopic analyses. Abietane diterpenoids were isolated from the plant for the first time. All isolates were tested for their neuroprotective activities against H2O2-induced SH-SY5Y cells injury, and compound 2 showed moderate effect at the concentrations ranging from 5 ∼ 20 μM in vitro assay. Graphical Abstract